84 related articles for article (PubMed ID: 19646570)
21. TfR2 expression in human colon carcinomas.
Calzolari A; Deaglio S; Maldi E; Cassoni P; Malavasi F; Testa U
Blood Cells Mol Dis; 2009; 43(3):243-9. PubMed ID: 19729324
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells.
Menon V; Thomas R; Elgueta C; Horl M; Osborn T; Hallett PJ; Bartos M; Isacson O; Pruszak J
Stem Cells; 2019 Oct; 37(10):1293-1306. PubMed ID: 31381839
[TBL] [Abstract][Full Text] [Related]
23. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive profiling of the cell surface proteome of Sy5Y neuroblastoma cells yields a subset of proteins associated with tumor differentiation.
Garcia J; Faca V; Jarzembowski J; Zhang Q; Park J; Hanash S
J Proteome Res; 2009 Aug; 8(8):3791-6. PubMed ID: 19505085
[TBL] [Abstract][Full Text] [Related]
25. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
26. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
[TBL] [Abstract][Full Text] [Related]
27. WT-1 immunohistochemical expression in small round blue cell tumours.
McCluggage WG
Histopathology; 2008 Apr; 52(5):631-2. PubMed ID: 18312358
[No Abstract] [Full Text] [Related]
28. Multiple myeloma with loss of CD138 expression in two rare metastatic localizations, peritoneum and skin.
Svrcek M; Meignin V; Brière J; Quillard J; Mariette X; Audouin J; Janin A
Histopathology; 2007 Jun; 50(7):952-4. PubMed ID: 17543089
[No Abstract] [Full Text] [Related]
29. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
[TBL] [Abstract][Full Text] [Related]
30. CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis.
Boivin M; Lane D; Piché A; Rancourt C
Gynecol Oncol; 2009 Dec; 115(3):407-13. PubMed ID: 19747716
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric detection of small cell lung cancer cells with aberrant CD45 expression in micrometastatic bone marrow.
Danbara M; Yoshida M; Kanoh Y; Jiang SX; Masuda N; Akahoshi T; Higashihara M
Jpn J Clin Oncol; 2009 Nov; 39(11):771-5. PubMed ID: 19674995
[TBL] [Abstract][Full Text] [Related]
32. Quantitative differences in protein expression between cisplatin sensitive C0C1 ovarian carcinoma cells and cisplatin resistant C0C1/DDP cells.
Wang HX; Sun W; Li HL; Zhang WY
Chin Med J (Engl); 2009 Apr; 122(7):865-9. PubMed ID: 19493403
[No Abstract] [Full Text] [Related]
33. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
Guo LM; Pu Y; Han Z; Liu T; Li YX; Liu M; Li X; Tang H
FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
[TBL] [Abstract][Full Text] [Related]
34. A case of dysgerminoma of the ovary with early carcinomatous features.
Ohta Y; Suzuki T; Ikeda K; Saito K; Shiokawa A; Mitsuya T; Kushima M; Ota H
Histopathology; 2007 Aug; 51(2):269-71. PubMed ID: 17593215
[No Abstract] [Full Text] [Related]
35. Development of a novel ovarian cancer molecular target therapy against cancer-related transcriptional factor, NAC1.
Nakayama K; Nakayama N; Miyazaki K
J Obstet Gynaecol Res; 2013 Jan; 39(1):18-25. PubMed ID: 22845777
[No Abstract] [Full Text] [Related]
36. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
Kandil DH; Cooper K
Adv Anat Pathol; 2009 Mar; 16(2):125-9. PubMed ID: 19550373
[TBL] [Abstract][Full Text] [Related]
37. eEF1A2 as a putative oncogene.
Lee MH; Surh YJ
Ann N Y Acad Sci; 2009 Aug; 1171():87-93. PubMed ID: 19723040
[TBL] [Abstract][Full Text] [Related]
38. Quantitative identification of blood cell markers in human hematopoietic malignancies with diagnostic and prognostic significance.
Kusenda J
Neoplasma; 2008; 55(5):381-6. PubMed ID: 18665747
[TBL] [Abstract][Full Text] [Related]
39. Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma.
Liu JF; Hirsch MS; Lee H; Matulonis UA
Gynecol Oncol; 2009 Dec; 115(3):401-6. PubMed ID: 19796795
[TBL] [Abstract][Full Text] [Related]
40. Forensic bioinformatician aims to solve mysteries of biomarker studies.
Savage L
J Natl Cancer Inst; 2008 Jul; 100(14):983-7. PubMed ID: 18612123
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
